Comprehensive clinical guide covering PAD, AAA, carotid surgery, DVT/PE, diabetic vascular disease, limb assessment, and post-operative vascular care — with interactive tools calibrated for the GCC healthcare environment, where diabetes and hypertension rates are among the world's highest.
PAD results from atherosclerotic narrowing of peripheral arteries, reducing blood flow to the limbs. In GCC populations, diabetes and smoking (particularly in male expatriate workers) accelerate the process significantly.
| Category | Grade | Clinical Description | Typical ABI |
|---|---|---|---|
| 0 | 0 | Asymptomatic | 0.7–0.9 |
| 1 | I | Mild claudication | 0.5–0.8 |
| 2 | I | Moderate claudication | 0.5–0.8 |
| 3 | I | Severe claudication | <0.5 |
| 4 | II | Ischaemic rest pain | <0.4 |
| 5 | III | Minor tissue loss (ulcer/focal gangrene) | <0.4 |
| 6 | III | Major tissue loss (extending gangrene) | <0.4 |
AAA is defined as aortic diameter ≥3 cm (infrarenal). Rupture risk increases sharply above 5.5 cm. GCC screening programs mirror NICE/ACC guidelines.
Carotid stenosis is a major source of embolic stroke. Atherosclerotic plaque at the carotid bifurcation sheds emboli to the cerebral circulation.
| Clinical Feature | Score |
|---|---|
| Active cancer (treatment within 6 months) | +1 |
| Paralysis, paresis, or immobilisation of leg | +1 |
| Bedridden >3 days or major surgery <4 weeks | +1 |
| Local tenderness along deep venous system | +1 |
| Entire leg swollen | +1 |
| Calf swelling >3 cm vs asymptomatic side | +1 |
| Pitting oedema (greater in symptomatic leg) | +1 |
| Collateral superficial veins | +1 |
| Alternative diagnosis as likely as DVT | −2 |
Pulmonary Embolism Severity Index stratifies 30-day mortality risk to guide treatment intensity.
| Class | Clinical Description | Management |
|---|---|---|
| C0 | No visible or palpable signs of venous disease | Reassurance, lifestyle |
| C1 | Telangiectasia / reticular veins | Cosmetic sclerotherapy |
| C2 | Varicose veins >3 mm | Compression + EVLA/foam |
| C3 | Oedema (venous origin) | Compression stockings |
| C4 | Skin changes (lipodermatosclerosis, eczema) | Compression + wound care |
| C5 | Healed venous ulcer | Long-term compression |
| C6 | Active venous ulcer | 4-layer compression + referral |
UAE (19.3%), Kuwait (23.1%), Saudi Arabia (18.7%) — among world's highest. PAD prevalence in diabetics is 3–4× non-diabetics. Vascular surgery units in GCC are predominantly managing diabetic foot complications.
Millions of blue-collar workers in UAE/Qatar/Saudi stand for 10–12 hour shifts in extreme heat, leading to dehydration and venous stasis — a significant but underreported DVT risk population.
2–3 million pilgrims annually; prolonged standing, cramped conditions, dehydration, and long-haul flights create a perfect storm for DVT/PE. Anticoagulation counselling for at-risk pilgrims is essential.
Midline laparotomy or retroperitoneal approach. Proximal aortic clamping, aneurysm sac opened, Dacron graft inserted.
Stent-graft deployed via femoral access under fluoroscopy. Requires suitable neck anatomy (>15 mm infrarenal neck, <60° angulation).
| Bypass Type | Indication | Preferred Conduit | Notes |
|---|---|---|---|
| Femoro-popliteal (above knee) | SFA occlusion, claudication/CLI | GSV or PTFE | Most common infrainguinal bypass |
| Femoro-popliteal (below knee) | Long SFA + popliteal disease | GSV preferred | PTFE with vein cuff if GSV unavailable |
| Femoro-distal (tibial/peroneal) | CLI, diabetic foot | GSV mandatory | Technically demanding; requires good runoff |
| Axillo-bifemoral | Aortoiliac disease, high-risk for aortic surgery | PTFE (8 mm ringed) | Extra-anatomic; infected aortic graft |
| Femoro-femoral crossover | Unilateral iliac occlusion | PTFE (8 mm) | Lower risk than aortobifemoral |
| Level | Abbreviation | Indication | Rehab Potential |
|---|---|---|---|
| Toe / Ray | — | Isolated digit gangrene, adequate perfusion | Excellent |
| Syme's (ankle disarticulation) | — | Forefoot gangrene, adequate heel circulation | Good (end-bearing stump) |
| Below Knee | BKA / TTA | Foot/distal gangrene, popliteal pulse present | Good — prosthesis well tolerated |
| Through Knee | TKA | Rarely used in vascular | Moderate |
| Above Knee | AKA / TFA | Extensive ischaemia, BKA failed, knee contracture | Lower — more energy expenditure |
| Hip Disarticulation | HD | Extensive proximal disease, wet gangrene | Limited |
Gold standard for haemodialysis access. Anastomosis between radial artery and cephalic vein at wrist (end-to-side or side-to-side).
| Component | Vascular-Specific Focus |
|---|---|
| A — Airway | Post-CEA: expanding neck haematoma = airway threat; have airway trolley at bedside |
| B — Breathing | Post-AAA: atelectasis, ARDS (aortic cross-clamp reperfusion); SpO₂ monitoring |
| C — Circulation | Haemodynamic stability, pulse quality, graft patency (assess q1h × 24h) |
| D — Disability | Post-CEA: NIHSS neuro check; post-AAA: leg movement (spinal cord ischaemia) |
| E — Exposure | Wound inspection: groin haematoma, graft limb pulses, wound dehiscence |
| V — Vascular | 6 Ps assessment: Pain, Pallor, Pulselessness, Paraesthesia, Paralysis, Poikilothermia |
Enter your clinical findings for each of the 6 Ps to receive an ischaemia risk level and recommended action.
| Agent | Indication | Monitoring |
|---|---|---|
| UFH infusion | Immediately post-bypass (first 24–48h) | aPTT 60–80 sec (1.5–2× control) |
| LMWH (enoxaparin) | DVT prophylaxis, bridge to warfarin | Anti-Xa if renal impairment |
| Warfarin | Prosthetic graft, AF, hypercoagulable state | INR 2.0–3.0 (load gradually) |
| Aspirin 75–100 mg | All vascular surgery patients post-op | None routine |
| Clopidogrel 75 mg | Dual antiplatelet post-stenting, EVAR | None routine |
| DOAC (rivaroxaban) | DVT treatment, selected PAD (COMPASS trial) | Renal function |
| Grade | Description | Clinical Significance |
|---|---|---|
| 0 | Absent — not palpable | Critical ischaemia likely; confirm with Doppler |
| 1+ | Barely palpable / thread-like | Severely reduced flow — urgent assessment |
| 2+ | Diminished but present | Reduced flow — monitor closely, investigate |
| 3+ | Normal / expected | Adequate peripheral flow |
| 4+ | Bounding / hyperdynamic | AV fistula, aortic regurgitation, high output states |
| Pulse | Location | Technique |
|---|---|---|
| Femoral | Mid-inguinal point (midway between ASIS and pubic symphysis) | 2–3 finger pads, firm pressure; pulsatile mass in AAA/aneurysm |
| Popliteal | Popliteal fossa — knee slightly flexed | Both thumbs on tibial tuberosity, fingers wrap into fossa — requires firm pressure; easy to miss |
| Dorsalis Pedis (DP) | Dorsum of foot, lateral to extensor hallucis longus tendon | Light touch with 2–3 fingers; absent in 10% normal population |
| Posterior Tibial (PT) | Behind medial malleolus | Firm pressure posterior to medial malleolus; more reliable than DP for ischaemia assessment |
Enter the highest ankle systolic BP (dorsalis pedis or posterior tibial) and the higher brachial systolic BP. ABI = Ankle SBP ÷ Brachial SBP.
| ABI Value | Interpretation | Clinical Action |
|---|---|---|
| >1.3 | Non-compressible vessels (calcification) | Use toe-brachial index (TBI); common in GCC diabetics |
| 0.9–1.3 | Normal | Routine surveillance in at-risk patients |
| 0.7–0.89 | Mild PAD | Lifestyle, risk factor modification, antiplatelet |
| 0.4–0.69 | Moderate PAD | Vascular review, consider imaging + revascularisation |
| <0.4 | Severe / Critical Ischaemia | Urgent vascular referral — limb-threatening |
Occurs in 50–80% of amputees. Pain perceived in the absent limb — distinct from stump pain. Central sensitisation mechanism.
Charcot neuroarthropathy is a devastating complication of peripheral neuropathy — rapid bone and joint destruction driven by unrecognised trauma and autonomic dysfunction.
| Eichenholtz Stage | Features | Management |
|---|---|---|
| Stage 0 | Hot, swollen foot; no X-ray changes yet; MRI shows bone oedema | Total contact cast (TCC) offloading immediately; no weight-bearing |
| Stage I | Fragmentation — fractures, dislocations visible on X-ray | Strict non-weight bearing; TCC; months of immobilisation |
| Stage II | Coalescence — bone repair begins; less warmth | Transition to removable cast boot (CAM walker) |
| Stage III | Consolidation — stable deformity | Custom footwear/orthosis; surgical reconstruction if unstable |
Diabetic PAD tends to be tibial/below-knee in distribution, often with multi-level disease. The choice between bypass and angioplasty depends on anatomy, patient fitness, and available conduit.
| Factor | Favours Angioplasty | Favours Bypass |
|---|---|---|
| Patient fitness | High anaesthetic risk | Good surgical candidate |
| Lesion length | Short (<10 cm), focal | Long occlusion, multi-segment |
| Conduit available | No suitable vein | Good quality GSV |
| Urgency | Acute/urgent limb | Elective planning |
| TASC classification | A and B lesions | C and D lesions |
The angiosome concept maps foot territories to specific tibial arteries. Revascularising the artery directly supplying the wound ("direct revascularisation") improves healing rates vs indirect revascularisation.
| Foot Territory | Supplying Artery |
|---|---|
| Heel (plantar) | Posterior tibial → medial/lateral plantar |
| Dorsum of foot | Anterior tibial → dorsalis pedis |
| Lateral forefoot | Peroneal → lateral calcaneal |
| Medial ankle | Posterior tibial → medial calcaneal |
Where direct revascularisation is anatomically impossible, collateral circulation to the angiosome may be augmented by indirect revascularisation.
High Amputation Rates: Saudi Arabia, UAE, and Kuwait report among the highest rates of diabetes-related lower limb amputation globally. Contributing factors include:
Major Centres:
Renal transplant recipients — a large population in GCC due to high ESRD rates — face unique vascular complications relevant to nursing assessment. See also: Dialysis Nursing Guide.
15 questions covering ABI interpretation, 6 Ps, post-CEA care, AAA, DVT/PE, and diabetic vascular nursing. Select your answer then click Check to get immediate feedback.